Hottub News

New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program

2 reports from 2 outlets in 1 language · first reported · updated · JSON

HealthZipalertinibEGFRnon-small-cell lung carcinomaUnited States Food and Drug Administration

Reports

  1. NDA Submission Is Initiated for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion+ NSCLConclive.com · en ·
  2. New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review ProgramGlobeNewswire — all · en ·

More in Health

  1. Doctors warn about the risks energy drinks pose to kids. What families need to know74 outlets
  2. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola104 outlets
  3. Life expectancy almost back to pre-Covid levels, says WHO48 outlets
  4. Cat food investigation finds heavy metals, pesticides and plastic chemicals37 outlets
  5. More than 4000 Ebola deaths in Democratic Republic of Congo65 outlets
  6. Synthetic bee silk set to take sting out of wounds43 outlets